In the rapidly evolving pharmaceutical industry, contract manufacturing has emerged as a critical component, enabling companies to streamline production, reduce costs, and accelerate time to market. The global pharmaceutical contract manufacturing market size surpassed USD 182.86 billion in 2024 and is predicted to reach around USD 353.05 billion by 2034, registering a CAGR of 6.8% from 2025 to 2034. This impressive growth trajectory underscores the increasing reliance on contract manufacturers for innovation, scalability, and regulatory compliance.
read more..